Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
Abdul Razzak Bin Mohd Said, Adinegara B L Abas, Htoo Htoo Kyaw Soe, Han Ni, Nan Nitra Than, Jaspal Singh, Ifeyinwa Osunkwo
Publikováno v:
Cochrane Database Syst Rev
The Cochrane Library
The Cochrane Library
Background Sickle cell disease is a genetic chronic haemolytic and pro-inflammatory disorder. The clinical manifestations of sickle cell disease result from the presence of mutations on the beta globin genes that generate an abnormal haemoglobin prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf2be128c7522df769cf6fe1695a8de
https://europepmc.org/articles/PMC6464759/
https://europepmc.org/articles/PMC6464759/
Publikováno v:
The Cochrane Library
BACKGROUND: Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people. This is the third update of a Cochrane review first published in 1996. OBJECTIVES: To determine the effects of vitamin D or related compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a73ae7db4f326a54a2f4ced45cf13885
https://doi.org/10.1002/14651858.cd000227.pub3
https://doi.org/10.1002/14651858.cd000227.pub3
Autor:
George Wells, Peter Tugwell, G. H. Guyatt, Vivian Robinson, Lisa Waldegger, Nicole Zytaruk, Beverly Shea, Bruce Weaver, Ann Cranney, Jonathan D. Adachi, Alexandra Papaioannou
Publikováno v:
The Cochrane Library
BACKGROUND Postmenopausal osteoporosis results in an increased susceptibility to low-trauma fractures due to reduced bone volume and microarchitectural deterioration. Risedronate, a third generation bisphosphonate, has been shown in multiple clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39ba2079c55018f8d4a837f80a1448f0
https://doi.org/10.1002/14651858.cd004523
https://doi.org/10.1002/14651858.cd004523
Autor:
Ann Cranney, Vivian Robinson, George Wells, Jonathan D. Adachi, G. H. Guyatt, Beverly Shea, N. Krolicki, Lauren Griffith
Publikováno v:
The Cochrane Library
BACKGROUND Osteoporosis is a clinical syndrome of reduced bone mass and increased fracture susceptibility. There are now a number of options, including etidronate which can decrease the risk of fractures. OBJECTIVES To systematically review the effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09f74c2efcf8876ec02eed4c4540cb93
https://doi.org/10.1002/14651858.cd003376
https://doi.org/10.1002/14651858.cd003376